# Cigna Group vs Regeneron Pharmaceuticals: stocks compared

URL: https://funkfolio.com/compare/ci-vs-regn

> Cigna Group ($77.5B, P/E 13.0) and Regeneron Pharmaceuticals ($99.1B, P/E 21.2) compared: size, valuation, margins, debt, cash and price change.

---

## Cigna Group vs Regeneron Pharmaceuticals

Cigna Group (CI), health care, and Regeneron Pharmaceuticals (REGN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Regeneron Pharmaceuticals is worth $99.1B on the stock market and Cigna Group $77.5B: Regeneron Pharmaceuticals is valued at 28% more. Cigna Group trades at 13.0 times earnings and Regeneron Pharmaceuticals at 21.2; operating margins in their latest fiscal years were 3.35% and 24.9%. Over the past year Cigna Group's share price has moved +10.1% and Regeneron Pharmaceuticals's +31.3%.

### Key facts

- **Cigna Group market value:** $77.5B
- **Regeneron Pharmaceuticals market value:** $99.1B
- **Cigna Group P/E:** 13.0
- **Regeneron Pharmaceuticals P/E:** 21.2
- **Cigna Group revenue:** $274.9B FY to 2025-12-31
- **Regeneron Pharmaceuticals revenue:** $14.3B FY to 2025-12-31
- **Superinvestors holding both:** 4

Market values as of 17 Nov 2026, 21:47 UTC.

Cigna Group vs Regeneron Pharmaceuticals: every measure side by side

| Measure | Cigna Group | Regeneron Pharmaceuticals |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $77.5B lower | $99.1B higher |
| Revenue | $274.9B higher | $14.3B lower |
| Earnings | $6B higher | $4.5B lower |
| Employees | 65,669 higher | 15,410 lower |
| Total assets | $157.9B higher | $40.6B lower |
| Valuation |  |  |
| P/E | 13.0 lower | 21.2 higher |
| P/S | 0.3 lower | 6.9 higher |
| P/B | 1.8 lower | 2.9 higher |
| Dividend yield | 2.06% higher | 0.39% lower |
| Profitability |  |  |
| Operating margin | 3.35% lower | 24.9% higher |
| Balance sheet |  |  |
| Net assets | $41.7B higher | $31.3B lower |
| Total liabilities | $116B higher | $9.3B lower |
| Total debt | $31.5B higher | $2B lower |
| Cash on hand | $7.7B higher | $3.1B lower |
| Price change |  |  |
| Today | -2.03% lower | +0.56% higher |
| 1 year | +10.1% lower | +31.3% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Cigna Group 108.4, Regeneron Pharmaceuticals 136.0.

- Cigna Group (CI)
- Regeneron Pharmaceuticals (REGN)

Cigna Group and Regeneron Pharmaceuticals share prices over one year, rebased to 100: Cigna Group ends at 108.4, Regeneron Pharmaceuticals at 136.0.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | CI | REGN |
| --- | --- | --- |
| Nov 28, 2025 | 102.2 | 110.8 |
| Dec 31, 2025 | 101.4 | 109.6 |
| Jan 30, 2026 | 101.0 | 105.3 |
| Feb 27, 2026 | 106.8 | 111.0 |
| Mar 31, 2026 | 98.3 | 109.7 |
| Apr 30, 2026 | 107.1 | 100.4 |
| May 29, 2026 | 102.2 | 87.3 |
| Jun 30, 2026 | 101.6 | 88.5 |
| Jul 31, 2026 | 102.8 | 108.3 |
| Aug 31, 2026 | 101.8 | 113.5 |
| Sep 30, 2026 | 100.2 | 107.7 |
| Oct 30, 2026 | 109.9 | 131.7 |
| Nov 17, 2026 | 108.4 | 136.0 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (4)

- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 1.8% / 1.9%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 1.5% / 0.1%
- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 0.3% / 0.3%
- [John Overdeck and David Siegel (founders)](https://funkfolio.com/gurus/two-sigma) 0.3% / 0.5%

#### Cigna Group only (11)

- [Anthony Bozza](https://funkfolio.com/gurus/anthony-bozza) 6.0%
- [Andrew Wellington](https://funkfolio.com/gurus/andrew-wellington) 2.8%
- [Lew Sanders](https://funkfolio.com/gurus/lew-sanders) 2.7%
- [Christopher Davis](https://funkfolio.com/gurus/christopher-davis) 2.7%
- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 2.3%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 1.7%
- [Louis Bacon](https://funkfolio.com/gurus/louis-bacon) 0.8%
- [David Einhorn](https://funkfolio.com/gurus/david-einhorn) 0.6%
- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) 0.4%
- [Tweedy, Browne team](https://funkfolio.com/gurus/tweedy-browne) 0.2%
- [Rajiv Jain](https://funkfolio.com/gurus/rajiv-jain) &lt;0.1%

#### Regeneron Pharmaceuticals only (6)

- [Mason Hawkins](https://funkfolio.com/gurus/mason-hawkins) 5.0%
- [Harry Burn](https://funkfolio.com/gurus/harry-burn) 3.0%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.3%
- [Cliff Asness](https://funkfolio.com/gurus/cliff-asness) 0.2%
- [Joel Greenblatt](https://funkfolio.com/gurus/joel-greenblatt) 0.2%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Cigna Group / Regeneron Pharmaceuticals). [Who owns CI](https://funkfolio.com/stock/CI/superinvestors) · [Who owns REGN](https://funkfolio.com/stock/REGN/superinvestors)

### More on Cigna Group

- [Cigna Group (CI) stock page](https://funkfolio.com/stock/CI)
- [Cigna Group market cap](https://funkfolio.com/stock/CI/market-cap)
- [Cigna Group revenue](https://funkfolio.com/stock/CI/revenue)
- [Cigna Group P/E ratio](https://funkfolio.com/stock/CI/pe-ratio)
- [Cigna Group operating margin](https://funkfolio.com/stock/CI/operating-margin)
- [Cigna Group total debt](https://funkfolio.com/stock/CI/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Regeneron Pharmaceuticals

- [Regeneron Pharmaceuticals (REGN) stock page](https://funkfolio.com/stock/REGN)
- [Regeneron Pharmaceuticals market cap](https://funkfolio.com/stock/REGN/market-cap)
- [Regeneron Pharmaceuticals revenue](https://funkfolio.com/stock/REGN/revenue)
- [Regeneron Pharmaceuticals P/E ratio](https://funkfolio.com/stock/REGN/pe-ratio)
- [Regeneron Pharmaceuticals operating margin](https://funkfolio.com/stock/REGN/operating-margin)
- [Regeneron Pharmaceuticals total debt](https://funkfolio.com/stock/REGN/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Cigna Group against its closest peers

- [Cigna Group vs Elevance Health](https://funkfolio.com/compare/ci-vs-elv)
- [Cigna Group vs Takeda Pharmaceutical](https://funkfolio.com/compare/ci-vs-tak)
- [Cigna Group vs Cencora](https://funkfolio.com/compare/ci-vs-cor)

#### Regeneron Pharmaceuticals against its closest peers

- [Regeneron Pharmaceuticals vs Elevance Health](https://funkfolio.com/compare/elv-vs-regn)
- [Regeneron Pharmaceuticals vs GSK](https://funkfolio.com/compare/gsk-vs-regn)
- [Regeneron Pharmaceuticals vs HCA Healthcare](https://funkfolio.com/compare/hca-vs-regn)
- [Regeneron Pharmaceuticals vs CVS Health](https://funkfolio.com/compare/cvs-vs-regn)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Cigna Group or Regeneron Pharmaceuticals?**

By market value, Regeneron Pharmaceuticals is the larger: $99.1B against $77.5B for Cigna Group. By revenue in its latest fiscal year, Cigna Group is the larger: $274.9B against $14.3B for Regeneron Pharmaceuticals.

**Which has the higher P/E ratio?**

Regeneron Pharmaceuticals: 21.2, against 13.0 for Cigna Group. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Regeneron Pharmaceuticals: 24.9%, against 3.35% for Cigna Group. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

Cigna Group: 2.06%, against 0.39% for Regeneron Pharmaceuticals. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Cigna Group: $31.5B, against $2B for Regeneron Pharmaceuticals. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Cigna Group and Regeneron Pharmaceuticals?**

In their latest 13F filings, Dodge & Cox team, Jeremy Grantham (co-founder), Josef Lakonishok and John Overdeck and David Siegel (founders) hold both.

### Cite this page

Funkfolio, “Cigna Group vs Regeneron Pharmaceuticals”, data as of 17 November 2026. https://funkfolio.com/compare/ci-vs-regn

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
